Anti-Human C5 Therapeutic Antibody (Pexelizumab)
Recombinant humanized (from mouse) antibody expressed in CHO binding to human Complement component 5. Pexelizumab is a drug designed to reduce side effects of coronary artery bypass grafting and angioplasty, among other types of cardiac surgery. It is a single chain variable fragment of a monoclonal antibody targeted against component 5 of the complement system.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-901 |
| Pricing | Inquiry |
| Host | Mouse |
| Target | Complement component 5 |
| Species Reactivity | Human |
| Type | scFv |
| Applications | FuncS, IF, Neut, ELISA, FC, IP, ICC |
| Storage | Store it under sterile conditions at -20°C upon receiving. Recommend to pack the protein into smaller quantities for optimal storage. |